Antineoplaston therapy (A10/AS2-1)

· Burzynski Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Antineoplaston therapy (A10/AS2-1), covering 2017-02-20 to 2017-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma [Phase 2]